Sintilimab, Nab-Paclitaxel, and Carboplatin

Phase 2Small molecule

Sintilimab, Nab-Paclitaxel, and Carboplatin is one of 35 small molecule programs targeting Airway obstruction. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Airway ObstructionActive, not recruiting

Airway ObstructionPhase 2

Active, not recruiting

Competition

Competitive Landscape

39 competitors in Airway Obstruction

#DrugCompanyPhaseTrials

Brethine

Daliresp

Theo-Dur

Onbrez

Alvesco

AAzurity Pharmaceuticals

Kenalog

Adrenaline

SSamson Clinical Operations Pty Ltd

Approved

—8

Serevent

GGlaxo Dba Glaxosmithkline

Striverdi Respimat

Truphylline

TThe Searle Company Limited Pakistan

Approved

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2029

Phase 2Not yet recruiting

Airway Obstruction

NCT06604351

Clinical

Trials by Indication[1]

Airway obstruction1 trial

Bronchoscopic Cryoablation Combined With Chemo-Immunotherapy in NSCLC With Central Airway Obstruction

Not yet recruiting·HHunan Province Tumor Hospital·Phase 2·NCT06604351·39 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Sintilimab, Nab-Paclitaxel, and Carboplatin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Sintilimab, Nab-Paclitaxel, and Carboplatin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Sintilimab, Nab-Paclitaxel, and Carboplatin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hunan Province Tumor Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: HHunan Province Tumor Hospital

Sintilimab, Nab-Paclitaxel, and Carboplatin

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2029

Trials by Indication[1]

Airway obstruction1 trial

References

Drug Info

Quick Facts

Related News